// App-Quantinova.ai

: Late Breaking Abstract - Supplementation of iron in pulmonary hypertension (SIPHON): results from a randomised controlled crossover trial

Researchers

Presenter

  • Luke Howard

Principal Investigators

  • Jian-Guo He

  • John Wharton

  • Geoffrey Watson

  • Henning Gall

  • Hossein Ghofrani

  • Li Huang

  • David Kiely

  • Qin Luo

  • Karen Sheares

  • Lan Zhao

  • Martin Wilkins

Medical Centers

  • Imperial College, London, United Kingdom

  • Cancer Hospital, Beijing, China

  • University of Giessen, Giessen, Germany

  • Royal Hallamshire Hospital, Sheffield, United Kingdom

Locations

  • United Kingdom

  • China

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Ferric carboxymaltose

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Cross Over

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A